Key Biologics and Astarte Biologics Merge
Includes growth equity investment from Ampersand Capital Partners MEMPHIS, TN and BOTHELL, WA – August 7, 2018 – Key Biologics has completed its merger with Astarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. In conjunction with the merger, the new entity also received…
